InnoCare Pharma Limited (HKG:9969)
Hong Kong · Delayed Price · Currency is HKD 13.65
-0.83 (-5.73%)
Sep 10, 2026, 11:59 AM HKT
InnoCare Pharma Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, InnoCare Pharma stock has a consensus rating of "Strong Buy" and an average price target of $20.27. The average 1-year stock price forecast is 48.50% higher than the current stock price, while the lowest is $17.18 (+25.86%) and the highest is $22.75 (+66.67%).
Price Target: $20.27 (+48.50%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for InnoCare Pharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 10 | 11 | 8 | 8 |
| Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 11 | 12 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst SDIC Securities No rating | SDIC Securities | Buy Maintains $18.88 | Buy | Maintains | $18.88 | +38.32% | Aug 26, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $17.00 | Buy | Maintains | $17.00 | +24.54% | Aug 25, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Maintains $22.00 | Buy | Maintains | $22.00 | +61.17% | Aug 25, 2026 |
Unknown Analyst UBS No rating | UBS | Buy Maintains $21.40 | Buy | Maintains | $21.40 | +56.78% | Jul 15, 2026 |
Unknown Analyst Shenwan Hongyuan No rating | Shenwan Hongyuan | Buy Maintains $19.40 | Buy | Maintains | $19.40 | +42.12% | May 14, 2026 |
Financial Forecast
Revenue This Year
2.59B
from 2.37B
Increased by 9.07%
Revenue Next Year
2.93B
from 2.59B
Increased by 13.18%
EPS This Year
0.24
from 0.39
Decreased by -39.15%
EPS Next Year
0.18
from 0.24
Decreased by -25.00%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.